NOREPINEPHRINE BITARTRATE
These highlights do not include all the information needed to use NOREPINEPHRINE BITARTRATE INJECTION safely and effectively. See full prescribing information for NOREPINEPHRINE BITARTRATE INJECTION. NOREPINEPHRINE BITARTRATE injection, for intravenous use Initial U.S. Approval: 1950
Approved
Approval ID
fd398152-b428-4dca-8478-b691b909ee0e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 1, 2023
Manufacturers
FDA
NorthStar Rx LLC
DUNS: 830546433
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norepinephrine bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72603-180
Application NumberANDA217575
Product Classification
M
Marketing Category
C73584
G
Generic Name
norepinephrine bitartrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 1, 2023
FDA Product Classification
INGREDIENTS (3)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
NOREPINEPHRINE BITARTRATEActive
Quantity: 1 mg in 1 mL
Code: IFY5PE3ZRW
Classification: ACTIM
SODIUM METABISULFITEInactive
Code: 4VON5FNS3C
Classification: IACT